Brainstorm Cell Therapeutics Inc. (BCLI) Social Stream



Brainstorm Cell Therapeutics Inc. (BCLI): $2.28

0.20 (+9.62%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add BCLI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#128 of 334

in industry

Featured Post From StockTwits About BCLI

$BCLI Fellow longs, we all want the damn peer review already and as panic sets in some may sell fearing risk but I loaded a little more shares. I want to bring your attention yet another sad attempt by short sellers to instill fear. Previously they spread many other false rumors, but these; "bird" posters have shown their true feathers and flocked south. I called them out on the lie when they posted that someone; "a bird" told them the peer review would coincide with the QA update which was a lie. They want to make yet another fake timing. Sabby and friends are timing short closing to assuming 4+month publication, this will bleed until the data brings home the reality that approval will come be it outside or inside the USA first. The logical timeline to me is that the peer review has been sent on May 5th according to Chaim. Due to the load of data involved likely be one of those 4 month+ reviews. Trust the Raven of intuition, I await September and do your own DD GL2all
Samtosemi, published August 17, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!